SG Americas Securities LLC Raises Position in Revvity Inc. $RVTY

SG Americas Securities LLC boosted its holdings in shares of Revvity Inc. (NYSE:RVTY) by 186.8% in the 4th quarter, Holdings Channel.com reports. The institutional investor owned 123,173 shares of the company’s stock after buying an additional 80,226 shares during the period. SG Americas Securities LLC’s holdings in Revvity were worth $11,917,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in RVTY. CYBER HORNET ETFs LLC bought a new position in Revvity in the 2nd quarter worth about $32,000. MUFG Securities EMEA plc bought a new stake in shares of Revvity during the 2nd quarter valued at about $34,000. Headlands Technologies LLC bought a new stake in shares of Revvity during the 2nd quarter valued at about $49,000. Smartleaf Asset Management LLC grew its holdings in shares of Revvity by 56.8% during the third quarter. Smartleaf Asset Management LLC now owns 690 shares of the company’s stock worth $58,000 after purchasing an additional 250 shares in the last quarter. Finally, Quent Capital LLC purchased a new position in shares of Revvity during the third quarter worth about $71,000. 86.65% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

RVTY has been the topic of a number of recent analyst reports. Bank of America downgraded shares of Revvity from a “buy” rating to a “neutral” rating and set a $110.00 target price on the stock. in a research note on Monday, December 15th. Robert W. Baird set a $129.00 price target on shares of Revvity in a research note on Tuesday, February 3rd. Weiss Ratings lowered shares of Revvity from a “hold (c-)” rating to a “sell (d+)” rating in a report on Wednesday, March 18th. The Goldman Sachs Group began coverage on shares of Revvity in a research report on Tuesday, December 9th. They set a “neutral” rating and a $105.00 price objective on the stock. Finally, Barclays lifted their price objective on shares of Revvity from $115.00 to $118.00 and gave the stock an “overweight” rating in a report on Tuesday, February 3rd. Five research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and an average price target of $113.67.

Revvity Stock Performance

Shares of NYSE RVTY opened at $83.98 on Friday. The stock’s 50-day moving average is $98.16 and its 200 day moving average is $96.47. The stock has a market cap of $9.39 billion, a price-to-earnings ratio of 40.37, a P/E/G ratio of 1.78 and a beta of 1.10. Revvity Inc. has a 1-year low of $81.36 and a 1-year high of $118.30. The company has a current ratio of 1.68, a quick ratio of 1.40 and a debt-to-equity ratio of 0.36.

Revvity (NYSE:RVTY) last issued its earnings results on Monday, February 2nd. The company reported $1.70 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.55 by $0.15. Revvity had a return on equity of 7.92% and a net margin of 8.45%.The business had revenue of $772.06 million during the quarter, compared to analyst estimates of $759.81 million. During the same quarter in the prior year, the firm earned $1.42 earnings per share. Revvity’s revenue for the quarter was up 5.9% on a year-over-year basis. Revvity has set its FY 2026 guidance at 5.350-5.450 EPS. On average, sell-side analysts anticipate that Revvity Inc. will post 4.94 EPS for the current fiscal year.

Revvity Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, May 8th. Stockholders of record on Friday, April 17th will be paid a $0.07 dividend. The ex-dividend date of this dividend is Friday, April 17th. This represents a $0.28 dividend on an annualized basis and a dividend yield of 0.3%. Revvity’s dividend payout ratio is 13.46%.

Revvity Company Profile

Revvity, Inc is a global provider of technology-enabled solutions for the life sciences, diagnostics and applied markets. The company develops and supplies a range of products and services, including reagents and consumables, laboratory instruments, workflow automation, software analytics and technical support. Its portfolio supports applications in drug discovery, genomics, cell biology research, environmental and food safety testing, industrial quality control and clinical diagnostics.

Tracing its heritage to Perkin-Elmer, founded in 1937, Revvity began trading on the New York Stock Exchange under the ticker symbol RVTY in January 2024 following a corporate rebranding.